Consumer Health Neurology

NTT Research Foundation Establishes Pioneering Fellowship Program at Harvard to Explore the Physics of Intelligence

NTT Research Foundation funds Fellowship Program in new field of Physics of Intelligence. Field of study bridges computer science, brain science and phy...

 April 12, 2024 | News

Eisai and Biogen Seek FDA Approval for Monthly Alzheimer's Treatment Dosing

Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...

 April 01, 2024 | News

AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China

AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...

 March 25, 2024 | News

NeuExcell Therapeutics Launches Pioneering Gene Therapy Trial for Glioblastoma Patients

NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the ...

 March 22, 2024 | News

Cellectricon launches new Neuroinflammation Research Service

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Establish...

 March 13, 2024 | News

Ono Pharmaceutical Forms Strategic Alliance with Harvard University for Drug Discovery

 Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...

 March 12, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

 March 06, 2024 | News

Elevating Alzheimer's Detection: Aptamer Group's CSO Dr. David Bunka Discusses the Impact of Optimer Binders

  In a compelling conversation with BioPharma APAC, Dr. David Bunka, the Chief Scientific Officer (CSO) of Aptamer Group, unveils an ambitious endeav...

 March 01, 2024 | Interview

Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China

  “Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...

 February 28, 2024 | News

Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01

  In a significant stride towards Alzheimer's disease (AD) treatment, Oscotec Inc. in collaboration with ADEL Inc., has announced the initiation of f...

 February 26, 2024 | News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...

 February 23, 2024 | News

HKUST Neuroscientists Unveil Groundbreaking Blood Test for Alzheimer's with Over 96% Accuracy

Neuroscientists from the Hong Kong University of Science and Technology (HKUST), led by Prof. Nancy IP, have introduced a highly accurate universal diagnos...

 February 20, 2024 | News

Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...

 February 13, 2024 | News

ShiraTronics finishes Australian pilot study enrollment, gears up for pivotal clinical trial

Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For arou...

 February 07, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close